Edgen Stock·Sep 13 2025, 02:57戻る
戻る
Elanco Innovations Drive Growth: Credelio Quattro Achieves Blockbuster Status, Zenrelia Expands Globally
Edgen Stock·Sep 13 2025, 02:57
[1] Elanco Innovation Builds Momentum, Credelio Quattro(TM) Reaches Blockbuster Status[2] Elanco's Credelio Quattro hits $100 million sales milestone - Investing.com South Africa[3] Elanco Innovation Builds Momentum, Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Reaches Blockbuster Status - PR Newswire